In recent years, the advances concerning the biology behind the SCLC-transformation of EGFRM+ LAC have been substantial, whereas our understanding of the clinical course associated with this phenotypic change has been more limited, as clinical data have been obtained from case reports or small case series. The gene discussed is LCT; the disease is small cell lung carcinoma.